Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain.

Autor: Devitt KA; Department of Pathology and Laboratory Medicine, University of Vermont Medical Center, Burlington, Vermont, USA.; Larner College of Medicine at the University of Vermont, Burlington, Vermont, USA., Kern W; Department of Flow Cytometry, MLL Munich Leukemia Laboratory, Munich, Germany., Kajstura MA; Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA., Holl EK; Danaher Corporation, Washington, DC, USA., Hays AL; Scientific Office, BioAgilytix Labs, Durham, North Carolina, USA., Hedley BD; Pathology and Laboratory Medicine, London Health Sciences Centre, London, Ontario, Canada., Gonneau C; Flow Cytometry Department, Labcorp Central Laboratories Services, Geneva, Switzerland., Jellison ER; Department of Immunology, UCONN School of Medicine, Farmington, Connecticut, USA., McCloskey TW; Department of Research and Development, ICON Laboratory Services, Farmingdale, New York, USA., Mishra S; Bone Marrow Transplantation and Stem Cell Research Centre, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India., Rebeles J; Department of Diagnostics, bioAffinity Technologies, San Antonio, Texas, USA., Ouseph MM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

Publikováno v: Cytometry. Part B, Clinical cytometry [Cytometry B Clin Cytom] 2024 Jul 20. Date of Electronic Publication: 2024 Jul 20.